Keywords: cima, developing, fast-melt, zomig, labs, version, zeneca

Cima Developing Fast-Melt Zomig

Article | 22 January 1998

Cima Labs is developing a fast-melt version of Zeneca's migrainetherapy, Zomig (zolmitriptan), for the company. Cima is using its OraSolv ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in